drugset / Trial / NCT02169440
Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to investigate CYP2C9 inhibition by BIA 9-1067 through the assessment of its effect on the pharmacokinetics of S-warfarin, a substrate of CYP2C9.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Opicapone | Small molecule | 25 mg | — |
| Subject | Warfarin | Small molecule | 25 mg | — |